Get started
Author

Manuela Mura

Observed names: M Mura, M. Mura, Mura, Manuela
ORCID: 0000-0001-5435-8241
Observed ORCID: 0000-0001-5435-8241
OpenAlex ID: A5076928239
Identification of a targeted and testable antiarrhythmic therapy for long-QT syndrome type 2 using a patient-specific cellular model
2017 · Ashish Mehta, Chrishan J A Ramachandra, et al. · European Heart Journal · 133
Elucidating arrhythmogenic mechanisms of long-QT syndrome CALM1-F142L mutation in patient-specific induced pluripotent stem cell-derived cardiomyocytes
2017 · Marcella Rocchetti, Luca Sala, et al. · Cardiovascular Research · 126
PDF
Conditioned Medium From Human Amniotic Mesenchymal Stromal Cells Limits Infarct Size and Enhances Angiogenesis
2015 · Patrizia Danieli, Giuseppe Malpasso, et al. · Stem Cells Translational Medicine · 113
PDF
Human mesenchymal stromal cells do not express ACE2 and TMPRSS2 and are not permissive to SARS-CoV-2 infection
2020 · Maria A. Avanzini, Manuela Mura, et al. · Stem Cells Translational Medicine · 52
PDF
Synthetic extracellular matrix mimic hydrogel improves efficacy of mesenchymal stromal cell therapy for ischemic cardiomyopathy
2018 · Maria Chiara Ciuffreda, Giuseppe Malpasso, et al. · Acta Biomaterialia · 50
MTMR4 SNVs modulate ion channel degradation and clinical severity in congenital long QT syndrome: insights in the mechanism of action of protective modifier genes
2020 · Yee-Ki Lee, Luca Sala, et al. · Cardiovascular Research · 48
PDF
Therapeutic Efficacy of Mexiletine for Long QT Syndrome Type 2: Evidence From Human Induced Pluripotent Stem Cell–Derived Cardiomyocytes, Transgenic Rabbits, and Patients
2024 · Lia Crotti, Raquel Neves, et al. · Circulation · 40
NOS1AP polymorphisms reduce NOS1 activity and interact with prolonged repolarization in arrhythmogenesis
2020 · Carlotta Ronchi, Joyce Bernardi, et al. · Cardiovascular Research · 39
Induced pluripotent stem cell technology: Toward the future of cardiac arrhythmias
2017 · Massimiliano Gnecchi, Manuela Stefanello, et al. · International Journal of Cardiology · 39
The KCNH2-IVS9-28A/G mutation causes aberrant isoform expression and hERG trafficking defect in cardiomyocytes derived from patients affected by Long QT Syndrome type 2
2017 · Manuela Mura, Ashish Mehta, et al. · International Journal of Cardiology · 34
Combination of miRNA499 and miRNA133 Exerts a Synergic Effect on Cardiac Differentiation
2014 · Federica Pisano, Claudia Altomare, et al. · Stem Cells · 34
PDF
XPD mutations in trichothiodystrophy hamper collagen VI expression and reveal a role of TFIIH in transcription derepression
2012 · D. Orioli, E. Compe, et al. · Human Molecular Genetics · 26
Gene- and variant-specific efficacy of serum/glucocorticoid-regulated kinase 1 inhibition in long QT syndrome types 1 and 2
2023 · Federica Giannetti, Miriam Barbieri, et al. · EP Europace · 19
PDF
Use of hiPSC-Derived Cardiomyocytes to Rule Out Proarrhythmic Effects of Drugs: The Case of Hydroxychloroquine in COVID-19
2022 · Luca Sala, Vladislav Leonov, et al. · Frontiers in Physiology · 14
Cockayne syndrome group A and ferrochelatase finely tune ribosomal gene transcription and its response to UV irradiation
2021 · Manuela Lanzafame, Giulia Branca, et al. · Nucleic Acids Research · 11
PDF
Tuning Tissue Ingrowth into Proangiogenic Hydrogels via Dual Modality Degradation
2019 · Cindy Chokoza, Carla A. Gustafsson, et al. · ACS Biomaterials Science & Engineering · 10
Generation of the human induced pluripotent stem cell (hiPSC) line PSMi002-A from a patient affected by the Jervell and Lange-Nielsen syndrome and carrier of two compound heterozygous mutations on the KCNQ1 gene
2018 · Manuela Mura, Yee-ki Lee, et al. · Stem Cell Research · 6
PDF
Generation of the human induced pluripotent stem cell (hiPSC) line PSMi003-A from a patient affected by an autosomal recessive form of Long QT Syndrome type 1
2018 · Manuela Mura, Monia Ginevrino, et al. · Stem Cell Research · 6
Mesenchymal Stromal Cell Secretome for Tissue Repair
2020 · Massimiliano Gnecchi, Maria Chiara Ciuffreda, et al. · Springer eBooks · 5
Generation of the human induced pluripotent stem cell (hiPSC) line PSMi006-A from a patient affected by an autosomal recessive form of long QT syndrome type 1
2019 · Manuela Mura, Francesca Bastaroli, et al. · Stem Cell Research · 4
PDF
Generation of two human induced pluripotent stem cell (hiPSC) lines from a long QT syndrome South African founder population
2019 · Manuela Mura, Federica Pisano, et al. · Stem Cell Research · 4
PDF
Generation of the human induced pluripotent stem cell (hiPSC) line PSMi007-A from a Long QT Syndrome type 1 patient carrier of two common variants in the NOS1AP gene
2019 · Manuela Mura, Federica Pisano, et al. · Stem Cell Research · 4
PDF
Optimized lentiviral transduction of human amniotic mesenchymal stromal cells
2017 · Federica Pisano, Manuela Mura, et al. · Pharmacological Research · 4
Generation of the human induced pluripotent stem cell (hiPSC) line PSMi004-A from a carrier of the KCNQ1-R594Q mutation
2019 · Manuela Mura, Yee-Ki Lee, et al. · Stem Cell Research · 3
PDF
Machine learning-guided risk stratification for long QT syndrome genetic variants with hiPSC-derived cardiomyocytes
2026 · Aleksandr Khudiakov, Manuela Mura, et al. · Cardiovascular Research · 2
Works count: 59
Citation count: 836
H-index: 14
I10-index: 16
Year
Topic
Type